1,091 results on '"Niu, Ting"'
Search Results
2. Adult acute leukemia patients with gram-negative bacteria bloodstream infection: Risk factors and outcomes of antibiotic-resistant bacteria
3. Transformation risk and associated survival outcome of marginal zone lymphoma: A nationwide study
4. Variable phenotypes and outcomes associated with the MMACHC c.482G > A mutation: follow-up in a large CblC disease cohort
5. Switching from eltrombopag to hetrombopag in patients with primary immune thrombocytopenia: a post-hoc analysis of a multicenter, randomized phase III trial
6. Hemophagocytic lymphohistiocytosis: current treatment advances, emerging targeted therapy and underlying mechanisms
7. Modest survival benefits of autologous stem cell transplantation in multiple myeloma with renal impairment: a critical appraisal of the pre-antibody era
8. Maintenance therapy for cytogenetically high-risk multiple myeloma: landscape in the era of novel drugs
9. Multiple myeloma: signaling pathways and targeted therapy
10. Correction to: Preclinical studies of Flonoltinib Maleate, a novel JAK2/FLT3 inhibitor, in treatment of JAK2V617F-induced myeloproliferative neoplasms
11. Early progression is associated with worse survival in patients with Waldenström’s macroglobulinemia
12. Clinical and diagnostic values of metagenomic next-generation sequencing for infection in hematology patients: a systematic review and meta-analysis
13. Fc receptor-like 5 (FCRL5)-directed CAR-T cells exhibit antitumor activity against multiple myeloma
14. Ferroptosis-related prognostic model of mantle cell lymphoma
15. Circ_0012152 Accelerates Acute Myeloid Leukemia Progression through the miR-652-3p/SOX4 Axis
16. Myelomonocytic and monocytic acute myeloid leukemia demonstrate comparable poor outcomes with venetoclax-based treatment: a monocentric real-world study
17. Dihydrolipoamide dehydrogenase (DLD) is a novel molecular target of bortezomib
18. Targeted agents plus CHOP compared with CHOP as the first-line treatment for newly diagnosed patients with peripheral T-cell lymphoma (GUIDANCE-03): an open-label, multicentre phase 2 clinical trial
19. A multicenter prospective study of next-generation sequencing-based newborn screening for monogenic genetic diseases in China
20. Delivery of CD47-SIRPα checkpoint blocker by BCMA-directed UCAR-T cells enhances antitumor efficacy in multiple myeloma
21. RNA-binding protein hnRNPU regulates multiple myeloma resistance to selinexor
22. The characteristics and long-term outcomes of acute promyelocytic leukemia patients with early intracranial hemorrhage
23. LFA-1 knockout inhibited the tumor growth and is correlated with treg cells
24. Characterization and application of a lactate and branched chain amino acid metabolism related gene signature in a prognosis risk model for multiple myeloma
25. Multidisciplinary recommendations for the management of CAR-T recipients in the post-COVID-19 pandemic era
26. Epigenetic regulation in hematopoiesis and its implications in the targeted therapy of hematologic malignancies
27. Methylcrotonyl-CoA carboxylase subunit 1 (MCCA) regulates multidrug resistance in multiple myeloma
28. Development of low rare-earth containing magnesium alloy with high strength-ductility synergy by engineering nano-spaced lamellae
29. Chronic active Epstein-Barr virus infection involving gastrointestinal tract with hemophagocytic lymphohistiocytosis
30. Neuroprotective effect of 20 (S) - Protopanaxadiol (PPD) attenuates NLRP3 inflammasome-mediated microglial pyroptosis in vascular dementia rats
31. Influence of minor RE addition on microstructures, tensile properties, and creep resistance in a die-cast Mg–Al–Ca–Mn alloy
32. Melphalan-loaded methoxy poly(ethylene glycol)-poly(d,l-lactide) copolymer nanomicelles in the treatment of multiple myeloma
33. Combinations of ivermectin with proteasome inhibitors induce synergistic lethality in multiple myeloma
34. Romiplostim in primary immune thrombocytopenia that is persistent or chronic: phase III multicenter, randomized, placebo-controlled clinical trial in China
35. Etoposide, dexamethasone, and pegaspargase with sandwiched radiotherapy in early-stage natural killer/T-cell lymphoma: A randomized phase III study
36. Enhanced heat resistance of a sand-cast Mg-Sm-Zn-Zr alloy due to the co-precipitation of basal and prismatic phases by minor Nd addition
37. BCMA-targeting chimeric antigen receptor T-cell therapy for multiple myeloma
38. Subcutaneous injection of a bortezomib-loaded thermosensitive hydrogel for the treatment of multiple myeloma
39. Daratumumab, Bortezomib, and Dexamethasone versus Bortezomib and Dexamethasone in Chinese Patients With Relapsed or Refractory Multiple Myeloma: Updated Analysis of LEPUS
40. A systematic review on performance analysis of critical time points in multiple myeloma treated by CAR-T cell immunotherapy
41. Negative air ion exposure ameliorates depression-like behaviors induced by chronic mild stress in mice
42. BCL-2 isoform β promotes angiogenesis by TRiC-mediated upregulation of VEGF-A in lymphoma
43. Plerixafor as a preemptive or salvage therapy for healthy donors with poor mobilization of hematopoietic stem cells
44. Developing and validating a mortality prediction model for ICH in ITP: a nationwide representative multicenter study
45. Suppression of tumor growth and metastasis in Shkbp1 knockout mice
46. Symptom clusters and quality of life in ambulatory patients with multiple myeloma
47. A comprehensive and systematic analysis of Dihydrolipoamide S-acetyltransferase (DLAT) as a novel prognostic biomarker in pan-cancer and glioma.
48. Amyloid-Like Protein-Modified Carbon Nitride as a Bioinspired Material for Enhanced Photocatalytic CO2 Reduction.
49. Advances in Drug Delivery Systems for the Treatment of Acute Myeloid Leukemia.
50. Dose tapering to withdrawal stage and long‐term efficacy and safety of hetrombopag for the treatment of immune thrombocytopenia: Results from an open‐label extension study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.